Cortexyme - International Biopharmaceutical Industry

Current Edition

news

Cortexyme to shift focus after FDA places hold on experimental Alzheimer’s drug

Dive Brief: The Food and Drug Administration has ordered California biotech Cortexyme to stop testing of an experimental Alzheimer's disease drug, notifying the dr...

27 January 2022 news Alzheimer | Biotech

Continue Reading →

news

Cortexyme plans path forward for Alzheimer’s drug that failed study

Faced with the failure of a key clinical trial, a California-based biotech is pressing ahead with plans to test its experimental Alzheimer's drug in another study, co...

15 November 2021 news Alzheimer | Cortexyme

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Cortexyme to shift focus after FDA places hold on experimental Alzheimer’s drug

Cortexyme plans path forward for Alzheimer’s drug that failed study

International Biopharmaceutical Industry